Anti-CYP2D6 antibodies detected by quantitative radioligand assay and relation to antibodies to liver-specific arginase in patients with autoimmune hepatitis

Clinica Chimica Acta

Volumn 316, Issue 1-2, 2002, Pages 155-164

  Kimura, Masahiro ^a   Tatsumi, Ke Ita ^a   Tada, Hisato ^a   Izumi, Yukiko ^a   Kaneko, Akira ^b   Kato, Michio ^b   Masuzawa, Manabu ^b   Ikemoto, Masaki ^c   Yabusaki, Yoshiyasu ^d   Hidaka, Yoh ^a   Amino, Nobuyuki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA NATIONAL HOSPITAL   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d SUMITOMO CHEMICAL CO LTD   (Japan)

Author keywords

Autoimmune hepatitis; CYP2D6 antibodies

Indexed keywords

ANTIBODY; ARGINASE; CYTOCHROME P450 2D6; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SPECIFICITY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RADIOIMMUNOASSAY; TISSUE SPECIFICITY;

ANTIBODY SPECIFICITY; ARGINASE; AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP2D6; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER; MALE; MIDDLE AGED; RADIOLIGAND ASSAY;

HEPATITIS C VIRUS;

EID: 0036136123     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00747-1     Document Type: Article

References (39)

1. Autoimmune hepatitis
2. Autoimmune hepatitis: Pathogenesis, diagnosis and treatment
3. Autoimmune hepatitis
4. Meeting report: International Autoimmune Hepatitis Group
5. International Autoimmune Hepatitis Group report: Review of criteria for diagnosis of autoimmune hepatitis
6. Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection
7. A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: A sensitive and quantitative radioligand assay
8. Microsomal antibodies in active chronic hepatitis and other disorders
9. Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: Second type of "Autoimmune" hepatitis
10. Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis
11. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis
12. Antibodies to soluble liver antigen, P450IID6 and mitochondrial complexes in chronic hepatitis
13. Frequency and significance of antibodies to P450IID6 protein in Japanese patients with chronic hepatitis C
14. Antibodies to P450IID6, SLA, PDH-E2 and BCKD-E2 in Japanese patients with chronic hepatitis
15. Liver/kidney microsome antibody type 1 and hepatitis C virus infection
16. Non-organ specific autoantibodies associated with chronic C virus hepatitis
17. Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile
18. Autoimmune hepatitis versus viral hepatitis C
19. Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera
20. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease
21. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes
22. Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection
23. Conformational epitopes on CYP2D6 are recognized by liver/kidney microsomal antibodies
24. Enzyme immunoassay for autoantibodies to human liver-type arginase and its clinical application
25. Postpartum onset of acute heart failure possibly due to postpartum autoimmune myocarditis: A report of three cases
26. Incidence of postpartum onset of disease among patients with rheumatoid arthritis
27. Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: Studies of seventy autopsied cases
28. The human debrisoquine 4-hydroxylase (CYP2D) locus: Sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene
29. Multiple forms of human P450 expressed in Saccharomyces cerevisiae. Systematic characterization and comparison with those of the rat
30. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: The role of interferon in the development of autoimmune diseases
31. A novel assay for detecting antibodies to cytochrome P4502D6, the molecular target of liver kidney microsomal antibody type 1
32. Present status of autoimmune hepatitis in Japan - Correlating the characteristics with international criteria in an area with a high rate of HCV infection
33. Detection of anti-LKM-1 (anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver diseases
34. 65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay
35. Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus
36. Antithyroid antibodies
37. High prevalence of transient post-partum thyrotoxicosis and hypothyroidism
38. Postpartum autoimmune thyroid syndrome: A model of aggravation of autoimmune disease
39. Prediction of postpartum onset of rheumatoid arthritis